Table 1.
Participant characteristics
| Characteristic | ||
|---|---|---|
| Gender, n (%) | Female | 14 (58%) |
| Male | 10 (42%) | |
| Diagnosis, n (%) | Haematological | 15 (62%) |
| Leukaemia | 8 | |
| Acute lymphoblastic leukaemia | 3 | |
| Acute myeloid leukaemia | 2 | |
| Acute promoyelocytic leukaemia | 2 | |
| Myelodysplasia | 1 | |
| Lymphoma | 7 | |
| Hodgkin’s lymphoma | 4 | |
| Non-Hodgkin’s lymphoma | 3 | |
| Central nervous system and brain tumours | 4 (17%) | |
| Ependymoma | 2 | |
| Craniopharyngioma | 1 | |
| Low-grade glioma | 1 | |
| Other solid tumours | 5 (21%) | |
| Ewing’s sarcoma | 1 | |
| Osteosarcoma | 1 | |
| Rhabdomyosarcoma | 2 | |
| Breast | 1 | |
| Treatment received, n (%) | Chemotherapy | 20 (83%) |
| Radiotherapy | 11 (46%) | |
| Surgery | 8 (33%) | |
| Bone marrow transplant | 5 (21%) | |
| No treatment | 1 (4%) | |
|
Age at study (years) Mean (range) |
23.9 (18–33) | |
|
Age at diagnosis (years) Mean (range) |
11.0 (2–18) | |
|
Time since diagnosis (years) Mean (range) |
11.6 (3–27) | |